Matrix metalloproteinase 9 (MMP-9) in patients with rheumatoid arthritis

REFERENCES

• Sawai T, Uzuki M, Takahashi Y et al.: Expression of the proteinases and cytokines in inflammation. Byouri to rinshou 10: 1033–1040, 1992 (in Japanese).
   Google Scholar
• Takahashi Y, Sawai T: Expression of the proteases and cytokines in inflammative disease. Saishini-gaku 47: 1929–1935, 1992 (in Japanese).
   Google Scholar
• Sawai T, Murakami K, Ontani Y et al.: Stromelysin synthesizing cells in the synovial tissues of rheumatoid arthritis demonstrated by in situ hybridization and immunohistochemical methods. Tohoku J Exp Med 160: 285–286, 1990.
   Google Scholar
• Sopata I, Dancemicz AM: Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochem Biophys Acta 370: 510–523, 1974.
   PubMed Web of Science ®Google Scholar
• Murphy G, Reynolds JJ, Bretz U et al: Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Biochem J 203: 209–221, 1982.
   PubMed Web of Science ®Google Scholar
• Morel F, Berthier S, Guillot B et al: Human neutrophil gelatinase is a collagenase type IV. Biochem Biophys Res Commun 191: 269–274, 1993.
   PubMedGoogle Scholar
• Hibbs MS: Expression of 92 kDa phagocyte gelatinase by inflammatory and connective tissue cells. Matrix Suppl 1: 51–57, 1992.
   Google Scholar
• Murphy G, Cockett MI, Ward RV et al: Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J 277: 277–279, 1991.
   PubMed Web of Science ®Google Scholar
• Hibbs MS, Hasty KA, Sayer JM et al: Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260: 2493–2500, 1985.
   PubMed Web of Science ®Google Scholar
• Hibbs MS, Hoidal JP, Kang AH et al: Expression of a metalloproteinase which degrades native type V collagen and denatured collagens by cultured alveolar macrophages. J Clin Invest 80: 1644–1650, 1987.
   PubMed Web of Science ®Google Scholar
• Tetlow LC, Lees M, Ogata Y et al: Differential expression of gelatinase B (MMP-9) and stromely-sin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 13: 53–59, 1993.
   PubMed Web of Science ®Google Scholar
• Clark SD, Kobayashi DK, Welgus HG: Regulation of the expression of tissue inhibitors of metal-loproteinases and collagenases by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 80: 1280–1288, 1987.
   PubMed Web of Science ®Google Scholar
• Unemori EN, Hibbs MS, Ament AP: Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88: 1656–1662, 1991.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig AL, Li YP, Stetler-Stevenson WG et al: Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts./Bone <i>Mineral Res 9: 549–556, 1994.
   Google Scholar
• Roony M, Condell D, Quinlan W et al: Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 31: 956–963, 1988.
   Google Scholar
• Nagase H, Barrett AJ, Woessner F Jr: Nomenclature and glossary of the matrix metalloproteinases. Matrix Supple 1: 421–424, 1992.
   PubMedGoogle Scholar
• Morodomi T, Ogata Y, Sasaguri Y et al: Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 285: 603–611, 1992.
   Google Scholar
• Naka K: Matrix metalloproteinase 9 in bone resorption. Kanazawa Univ Juzenigakkaizasshi 100: 948–961, 1991.
   Google Scholar
• Barrett AJ, Starkey PM: The interaction of o!2-macroglobulin with proteinases. Biochem J 133: 709–724, 1973.
   PubMed Web of Science ®Google Scholar
• Cawston TE, Galloway WA, Mercer E et al: Purification of rabbit bone inhibitor of collagenase. Biochem J 195: 159–165, 1981.
   PubMed Web of Science ®Google Scholar
• Fujimoto N, Iwata K: Immunoquantitative enzyme assay for matrix metalloproteinases and inhibitors. Connective Tissue 26: 237–244, 1994 (in Japanese).
   Google Scholar
• Sasaki T, Ishiguro N, Iwata H: MMPs and TIMPs. The Bone 8: 97–100, 1994 (in Japanese).
   Google Scholar
• Sawai T: The pathology of rheumatological disease. In Saishinnaikagakutaikei 25 Nakayamashoten: 89–107, 1993 (in Japanese).
   Google Scholar
• Peppin GJ, Weiss SJ: Activation of the endogenous metalloproteinase, gelatinase by triggered human neutrophils. Proc Natl Acad Sci USA 83: 4322–4326, 1986.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG, Krutzsch HC, Wacher MP et al: The activation of human type IV collagenase proenzyme. J Biol Chem 264: 1353–1356, 1989.
   PubMed Web of Science ®Google Scholar
• Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (Stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581–3584, 1992.
   PubMed Web of Science ®Google Scholar
• Lefebvre V, Peeters-Joris C, Vaes G: Production of gelatin-degrading matrix metalloproteinases (type IV collagenase) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and understimulation by interleukin-1 and tumor necrosis factor a. Biochem Biophys Acta 1094: 8–18, 1991.
   PubMed Web of Science ®Google Scholar
• Ogata Y, Pratta MA, Nagase H et al: Matrix metalloproteinase 9 (92-kDa gelatinase/type V coUagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1/6 and a protein kinase C activator. Exp Cell Res 201: 245–249, 1992.
   Google Scholar
• Hirose T, Reife RA, Smith GN et al: Characterization of type V coUagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19: 593–599, 1992.
   Google Scholar
• Krane MS: Mechanisms of tissue destruction in rheumatoid arthritis. In Arthritis and Allied Conditions, 11th edn, pp. 298–714. Lea and Febiger, Philadelphia, 1989.
   Google Scholar